EBOS (ASX:EBO) share price on watch after dividend surge

The EBOS Group Ltd (ASX: EBO) share price is one to watch this morning after double-digit earnings growth and an interim dividend surge.

| More on:
Telstra dividend upgrade best asx share price dividend growth represented by fingers walking along growing piles of coins upgrade

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The EBOS Group Ltd (ASX: EBO) share price is on watch this morning following the company's half-year results release.

What could move the EBOS share price?

EBOS is the largest and most diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products

This morning, the Kiwi healthcare group provided an update on its performance to 31 December 2020 (1H 2021). EBOS reported "strong momentum" throughout the period with another record result highlighted by double-digit earnings growth.

The EBOS share price will be one to watch today after the company reported group revenue for the half was up 6.3% to $4.7 billion. Underlying earnings before interest and tax (EBIT) also jumped 11.5% to $147.8 million in a strong half for the company.

Statutory net profit after tax (NPAT) surged 13.7% higher to $92.9 million while underlying NPAT was up 14.2% to $94.3 million.

In good news for shareholders, underlying earnings per share (EPS) was up 12.7% to 57.8 cents in 1H 2021. The EBOS share price is also worth watching after the company increased its interim dividend by 13.3% to 42.5 cents.

Based on yesterday's closing share price of $27.00, that represents a ~3.1% per annum dividend yield.

EBOS reported "very strong" performance across its healthcare and animal care business segments. Healthcare's underlying EBIT jumped 11.2% with animal care EBIT up 25.6% for the half.

Operating cash flow surged 33.0% higher to $98.7 million, underpinned by strong group performance.

EBOS completed the acquisition of CH2's vet distribution business for $9 million to boost its market position while also expanding its medical devices business with the recent Cryomed acquisition.

EBOS has continued to increase earnings across both its healthcare and animal care segments in recent years.

Foolish takeaway

The EBOS share price will be one to watch in early trade this morning after a record result for the Kiwi healthcare group. 

Double-digit earnings growth and broadly strong group performance, combined with a 13.3% interim dividend increase, make EBOS worth keeping an eye on today.

Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A piggy bank on the cloud in the blue sky symbolising a record high share price.
52-Week Highs

12 ASX 200 shares that smashed historical peak prices today

Twelve ASX 200 shares rose to new multi-year peaks in an otherwise quiet day of trading.

Read more »

A woman's hand draws a stylised 'Top Ten' on a projected surface.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors saw another day of mild gains for the stock market this Thursday.

Read more »

Two boats on the water with crates with the words trade war in the middle.
Share Market News

Trump's tariffs blocked by trade court: Which ASX 200 stocks could benefit the most?

These 3 ASX 200 stocks have heavy tariffs exposure.

Read more »

A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
Broker Notes

How this undervalued ASX All Ords share could rocket 80% in a year

A leading fund manager expects a big turnaround for this beaten-down ASX All Ords stock.

Read more »

Man looking happy and excited as he looks at his mobile phone.
Share Gainers

Why Champion Iron, Clarity Pharmaceuticals, St Barbara, and Woodside shares are charging higher today

These shares are having a good session today. But why are investors buying them?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why ALS, Black Cat, Boss Energy, and Soul Patts shares are falling today

These shares are falling on Thursday. Let's find out why.

Read more »

A car dealer stands amid a selection of cars parked in a showroom.
Broker Notes

Up 77% in a year, guess how much more upside Macquarie tips for Eagers Automotive shares

Macquarie released its latest analysis on Eagers Automotive fast rising shares this morning.

Read more »

Boy looks quizzical standing in front of a graph.
Share Market News

Big ASX 200 news! Stock market whipsaws as Trump's tariffs struck down

Markets initially surged on news that Trump's tariffs are out.

Read more »